• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed within each year since 1998, when FDA received its first GRAS notice. Once FDA has responded to a GRAS notice, the text of FDA's response will also be available as part of the record for that notice. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Search within these results
Records Found: 655 Show All Page 1 of 14
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
655 Rice bran wax Pending
654 Cocoa butter substitute Pending
653 Lysophospholipase from Aspergillus nishimurae expressed in Trichoderma reesei. Pending
652 Gamma linolenic acid safflower oil Pending
651 Phospholipase A1 from Talaromyces leycettanus produced in Aspergillus niger Pending
650 2'-O-fucosyllactose Pending
649 β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis Pending
648 Monoglycerides Pending
647 D-psicose Pending
646 Pecan shell fiber Pending
645 Pullulanase from Bacillus deramificans and Bacillus acidopullulyticus expressed in Bacillus licheniformis Pending
644 Non-fat dry goat milk and goat whey protein Pending
643 Phosphatidylserine derived from fish Pending
642 Camelina oil Pending
641 Pyrroloquinoline quinone disodium salt Pending
640 Esterified propoxylated glycerol Pending
639 Zeaxanthin from marigold Pending
638 High purity steviol glycosides (minimum purity 97%) consisting primarily of rebaudioside A Pending
637 Phosphatidylserine derived soy lecithin Pending
636 Phosphatidylserine derived from sunflower Pending
635 Nicotinamide riboside chloride Pending
634 Calcium chloride Pending
633 Whey protein Pending
632 Rebaudioside A from Yarrowia lipolytica Jun 24, 2016 FDA has no questions
631 Triacylglycerol lipase from Fusarium oxysporum produced in Trichoderma reesei Pending
630 Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella May 17, 2016 At the notifier's request, FDA ceased to evaluate this notice
629 Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract Pending
628 endo-1,4-beta-xylanase from Trichoderma reesei Pending
627 Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate Pending
626 Steviol glycosides produced in Saccharomyces cerevisiae May 27, 2016 FDA has no questions
625 Pyrroloquinoline quinone disodium salt Pending
624 D-allulose 3-epimerase from Arthrobacter globiformis M30 produced in Escherichia coli Pending
623 Fructooligosaccharides Pending
622 Emulsified fish oil May 13, 2016 At the notifier's request, FDA ceased to evaluate this notice
621 Emulsified algal oil May 13, 2016 At the notifier's request, FDA ceased to evaluate this notice
620 Galacto-oligosaccharides Pending
619 Purified steviol glycosides May 27, 2016 FDA has no questions
618 Purified seawater May 27, 2016 FDA has no questions
617 α-amylase from Cytophaga sp. produced in Bacillus licheniformis Apr 8, 2016 At the notifier's request, FDA ceased to evaluate this notice
616 Acetylated high amylose corn starch (85% amylose) Jun 24, 2016 FDA has no questions
615 High amylose corn starch (68% amylose) Jun 24, 2016 FDA has no questions
614 Chromium polynicotinate Apr 12, 2016 FDA has no questions
613 Apple peel powder Mar 8, 2016 At the notifier's request, FDA ceased to evaluate this notice
612 Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 May 19, 2016 At the notifier's request, FDA ceased to evaluate this notice
611 Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 Apr 15, 2016 At notifier's request, FDA ceased to evaluate the notice
610 Isomaltodextrin Jun 6, 2016 FDA has no questions
609 Rice protein Jun 6, 2016 FDA has no questions
608 Pea protein concentrate May 27, 2016 FDA has no questions
607 Glucosylated steviol glycosides (minimum purity 80%) Pending
606 Vinyl acetate-vinyl laurate copolymers May 27, 2016 FDA has no questions

Show All 

jump to page of 14 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter
-
-